B. Bowen et al., A review of the reported defects in the human C1 esterase inhibitor gene producing hereditary angioedema including four new mutations, CLIN IMMUNO, 98(2), 2001, pp. 157-163
C1 esterase inhibitor (C1INH) is an important regulatory protein of the cla
ssical pathway of complement. Mutations in the gene for this protein cause
the autosomal dominant disorder hereditary angioedema (HAE). Approximately
85% of patients with HAE have a Type I defect, characterized by a diminishe
d level of antigenic and functional C1INH. Patients with Type II defects ha
ve sufficient protein, but one allele produces dysfunctional protein. We ha
ve sequenced the DNA from HAE: patients and have discovered four previously
unreported mutations. The first mutation is a splice site error at nucleot
ide 8721, which changes the 3' acceptor splice site AG to GG at the end of
intron 5 at nucleotide 8721-8722. The second mutation is a single base inse
rtion in exon 3 between nucleotides 2467 and 2468. The third mutation is a
missense error present in the eighth exon of the C1INH; at nucleotide 16867
(amino acid 470), a T to A mutation transforms a Met to a Lys. The fourth
mutation closely resembles the third mutation in that it is a missense erro
r occurring in exon 8 in the distal hinge region; a T16827C substitution ch
anges the Phe at amino acid 457 to Leu. This report compiles a list of 97 d
istinct defects in the C1INH gene that cause hereditary angioedema. (C) 200
1 Academic Press.